U.S. Personal Products Stock News

Investors may be wondering whether PACS Group at around US$35.97 is still offering value after its strong run, or if the easy gains are already behind it. The stock has moved 11.9% over the last 7 days and 5.3% over the last 30 days, while the 1 year return of 286.8% contrasts with a year to date return of a 9.0% decline. Recent attention on PACS Group has centered on its strong 1 year share price performance and the healthcare services segment it operates in. This has made the stock more...

Prairie Operating Co. reported past full-year 2025 results on March 30, 2026, showing revenue of US$241.65 million versus US$7.94 million a year earlier and moving from a net loss of US$40.91 million to net income of US$32.05 million, alongside detailed production disclosure. Management also issued production and earnings guidance for 2026, targeting average daily output of 25,500–27,500 Boe/d and net income of US$55 million to US$65 million, highlighting how operational scale now ties...

Wondering if Oncolytics Biotech at US$1.04 is priced for its potential or already running ahead of itself? This article walks through what the numbers are actually saying about value. The stock shows mixed return figures, with a 7 day return of 8.3%, 30 day return of 2.0%, year to date return of 5.7%, a 1 year return of 108.0%, a 3 year return of 11.9% decline, and a 5 year return of 64.5% decline that some investors may see as a reset in expectations. Recent attention around Oncolytics...

Artificial intelligence in healthcare is attracting fresh attention as investors weigh higher for longer inflation risks, volatile bond yields, and energy driven cost pressures. While many sectors are wrestling with rising input and financing costs, AI in healthcare is focused on accuracy, efficiency, and better patient outcomes, themes that can matter across economic cycles. This article highlights 3 stocks from the Transformative AI Healthcare Stocks screener, a focused way to look at...

Applied Digital (APLD) just posted its Q3 2026 numbers, reporting revenue of US$126.6 million and a basic EPS loss of US$0.36. Trailing twelve month revenue came in at US$319.3 million, alongside a basic EPS loss of US$0.46. Over recent quarters, the company’s revenue has moved from US$38.0 million in Q4 2025 to US$64.2 million in Q1 2026, US$161.7 million in Q2 2026 and now US$126.6 million in Q3 2026. Over the same period, quarterly basic EPS shifted from a loss of US$0.12 to a loss of...

JD Bancshares (JDVB) just wrapped up FY 2025 with fourth quarter revenue of US$14.6 million and basic EPS of US$0.97, alongside trailing 12 month revenue of US$56.9 million and EPS of US$3.78, compared with FY 2024 trailing 12 month revenue of US$55.6 million and EPS of US$3.97. Over that same trailing 12 month window, net income moved from US$13.6 million in FY 2024 to US$13.0 million in FY 2025. This may prompt investors to focus on how margins and overall profitability quality shape the...

If you are wondering whether Spectrum Brands Holdings at about US$80.22 is offering fair value or hiding a margin of safety, you are asking the right question. The stock has delivered returns of 8.8% over the last 7 days, 6.2% over 30 days, 33.6% year to date and 35.2% over the last year, which naturally raises questions about how much of the story is already in the price. Recent coverage around Spectrum Brands Holdings has focused on its role in the Household Products space and how...

If you are wondering whether Teleflex's current share price reflects its true worth, this breakdown will help you see how the market price lines up with several valuation checks. The stock recently closed at US$120.27, with returns of 2.1% over the last week and 7.5% over the last month, while year to date it is down 1.7% and the 1 year return is a 5.7% decline. These mixed returns sit against a backdrop of ongoing attention on Teleflex as a medical equipment company, with investors weighing...

Labcorp Holdings, NYSE:LH, is expanding into specialized diagnostic testing, including oncology and neurology, through recent acquisitions and product launches. The company is reporting operational improvements and cost savings linked to business optimization and AI driven initiatives. These changes reflect a sharpened focus on higher growth testing segments and more efficient operations. Labcorp Holdings, NYSE:LH, enters this phase of expansion with its shares at $273.26 and a 26.3% return...

Byrna Technologies (BYRN) has just opened its Q1 2026 earnings season narrative following a Q4 2025 print that showed total revenue of US$35.2 million and basic EPS of US$0.15, with trailing twelve month revenue at US$118.1 million and basic EPS of US$0.43. Over recent quarters the company has seen revenue move from US$27.9 million in Q4 2024 to US$35.2 million in Q4 2025, while basic EPS shifted from US$0.43 to US$0.15. This sets up a results story where investors are likely to focus on how...

Resources Connection (RGP) has reported Q3 2026 revenue of US$107.9 million alongside a basic EPS loss of US$0.28, with trailing 12 month EPS at a loss of US$2.94 on revenue of US$485.2 million. The company has seen quarterly revenue move from US$145.6 million in Q2 2025 to US$129.4 million in Q3 2025 and then to US$107.9 million in Q3 2026. Over the same period, quarterly EPS moved from a loss of US$2.08 in Q2 2025 to a loss of US$1.34 in Q3 2025 and then to a loss of US$0.28 in Q3 2026,...

If you are wondering whether Skyward Specialty Insurance Group at around US$45.89 is offering fair value or a potential bargain, this article will help you put the current share price in context. The stock has risen 4.5% over the last 7 days, while returns sit at a 0.9% decline over 30 days, a 5.6% decline year to date and a 12.0% decline over the past year, compared with a very large 3-year return of 117.7%. Recent coverage has focused on Skyward Specialty Insurance Group's role within the...

Wondering if Kodiak AI at US$7.85 is a bargain or a value trap? This article walks through what the current price could be saying about the stock. The share price has moved 9.0% over the last 7 days, after a 9.5% decline over 30 days and a 27.5% fall year to date, with the 1 year return at 29.7% in the red. Recent coverage has focused on Kodiak AI as part of broader discussions about listed auto related and AI exposed names, with investors weighing business potential against ongoing...

If you are wondering whether PayPay's current share price reflects its true worth, this breakdown will help you size up what you are actually paying for. After closing at US$20.36, the stock has seen a 3.6% decline over the last 7 days while still showing a 12.1% gain year to date, which can change how investors see both risk and opportunity. Recent coverage around PayPay has focused on its position in the diversified financials space and how its business profile fits into broader market...

Wondering if Cirrus Logic at around US$154.82 is giving you fair value or asking too much for its growth story? This article breaks that question down in plain terms. The stock has shown strong recent returns, with 5.2% over 7 days, 15.6% over 30 days, 29.4% year to date, 71.6% over 1 year, 73.4% over 3 years, and 84.2% over 5 years, which naturally raises questions about how much optimism is already in the price. Recent coverage has focused on Cirrus Logic as part of wider discussions...

If you are wondering whether DoubleVerify Holdings is attractively priced or still too expensive, this breakdown will help you frame the current share price against what you might actually be paying for. The stock last closed at US$10.09, with returns of 3.2% over the past week, a 6.6% decline over the past month, and a 24.5% decline over the past year, which may have changed how the market is viewing its risk and reward trade off. Recent coverage has focused on DoubleVerify Holdings as an...

EA SPORTS has launched GEN / EA SPORTS, a new platform focused on connecting emerging athletes and fans through content and culture. The company signed high school athlete Elijah Haven as its first official ambassador, a first for the brand. The move signals EA SPORTS' intent to invest in younger talent and deepen its role across sports and entertainment communities. For investors watching Electronic Arts, NasdaqGS:EA, this launch comes with the stock trading at $203.99 and a 1 year return...

Liquidia (NasdaqCM:LQDA) is drawing attention after its investigational drug L606 was highlighted as a potential transformative therapy in the interstitial lung disease market. The candidate targets patients facing pulmonary hypertension and related conditions, positioning L606 as a possible new standard of care if clinical development progresses successfully. For investors tracking biopharma, Liquidia focuses on therapies for pulmonary hypertension and related respiratory conditions, an...

The United States market has shown robust performance, with a 3.0% rise over the last week and a 26% increase over the past year, while earnings are anticipated to grow by 16% annually in the coming years. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often reflect strong confidence from those closest to the business.

The United States market has shown robust performance, climbing 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors looking to capitalize on emerging trends.

Why Occidental Petroleum (OXY) is on investors’ radar Occidental Petroleum (OXY) has drawn fresh attention after recent trading left the shares at $59.77, set against a backdrop of mixed short term returns and a longer track record that includes both gains and setbacks. See our latest analysis for Occidental Petroleum. The recent 1 day share price return of a 5.04% decline contrasts with a 90 day share price return of 38.26% and a 1 year total shareholder return of 51.79%. This suggests...

Investors may be wondering whether Globe Life at US$147.85 is offering value right now, or if the recent share price move means they are late to the story. The stock has returned 5.3% over the last 7 days, 4.1% over the past month and 6.8% year to date, with a 21.6% return over 1 year, 41.4% over 3 years and 51.6% over 5 years. Recent coverage of Globe Life has focused on its position in the US insurance sector, with attention on how investors are weighing the stock against broader industry...

The United States market has shown robust growth, rising 3.0% over the last week and climbing 26% in the past year, with expectations of a 16% annual earnings increase in the coming years. In this thriving environment, identifying stocks that are potentially undervalued can present unique opportunities for investors seeking to capitalize on discrepancies between current stock prices and their intrinsic value.

The United States market has experienced a notable upswing, climbing 3.0% in the last 7 days and 26% over the past year, with earnings forecasted to grow by 16% annually. In this buoyant environment, dividend stocks can be an attractive option for investors seeking steady income and potential appreciation amidst positive market momentum.